Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Teerlink

Showing results (21-30 of 351) with videos related to

Pageof 36
Sort By:
Expert Opinion on Investigational Drugs|May 29, 2014
Serelaxin : a potential new drug for the treatment of acute heart failureNatalia Neverova, John R Teerlink
Lancet (London, England)|August 23, 2011
Medical therapy for chronic heart failureHenry Krum, John R Teerlink
Lancet (London, England)|May 25, 2020
Assessing the lifetime benefit of heart failure therapiesMitchell A Psotka, John R Teerlink
The Annals of Thoracic Surgery|May 23, 2002
Ventricular remodeling surgery for heart failure: small animals and how to measure an improvement in ventricular functionJohn R Teerlink, Mark B Ratcliffe
European Journal of Heart Failure|February 15, 2020
Systolic time intervals in patients with heart failure: time to teach new dogs old tricksJoyce N Njoroge, John R Teerlink
Current Heart Failure Reports|July 23, 2005
The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us?Mary Rose Fabi, John R Teerlink
Current Cardiology Reports|July 25, 2013
What's new in the treatment of acute heart failure?Van N Selby, John R Teerlink
Circulation|May 25, 2016
Ivabradine: Role in the Chronic Heart Failure ArmamentariumMitchell A Psotka, John R Teerlink
European Heart Journal. Acute Cardiovascular Care|July 5, 2021
Inotropic therapies in heart failure and cardiogenic shock: an educational reviewJacqueline T DesJardin, John R Teerlink
Current Treatment Options in Cardiovascular Medicine|October 7, 2011
Update on the Management of Acute Decompensated Heart FailureDavid T Majure, John R Teerlink
Pageof 36

Showing results (21-30 of 351) with videos related to

Sort By:
Pageof 36
Expert Opinion on Investigational Drugs|May 29, 2014
Serelaxin : a potential new drug for the treatment of acute heart failureNatalia Neverova, John R Teerlink
Lancet (London, England)|August 23, 2011
Medical therapy for chronic heart failureHenry Krum, John R Teerlink
Lancet (London, England)|May 25, 2020
Assessing the lifetime benefit of heart failure therapiesMitchell A Psotka, John R Teerlink
The Annals of Thoracic Surgery|May 23, 2002
Ventricular remodeling surgery for heart failure: small animals and how to measure an improvement in ventricular functionJohn R Teerlink, Mark B Ratcliffe
European Journal of Heart Failure|February 15, 2020
Systolic time intervals in patients with heart failure: time to teach new dogs old tricksJoyce N Njoroge, John R Teerlink
Current Heart Failure Reports|July 23, 2005
The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us?Mary Rose Fabi, John R Teerlink
Current Cardiology Reports|July 25, 2013
What's new in the treatment of acute heart failure?Van N Selby, John R Teerlink
Circulation|May 25, 2016
Ivabradine: Role in the Chronic Heart Failure ArmamentariumMitchell A Psotka, John R Teerlink
European Heart Journal. Acute Cardiovascular Care|July 5, 2021
Inotropic therapies in heart failure and cardiogenic shock: an educational reviewJacqueline T DesJardin, John R Teerlink
Current Treatment Options in Cardiovascular Medicine|October 7, 2011
Update on the Management of Acute Decompensated Heart FailureDavid T Majure, John R Teerlink
Pageof 36